VYVGART – Patient Worthy

https://pixabay.com/photos/hospital-infusion-hand-association-834157/

Positive Topline Data Available on VYVGART Hytrulo for People Living with CIDP

Post author:Jessica Lynn
Post published:July 27, 2023
Post category:Chronic Inflammatory Demyelinating Polyneuropathy

In June 2023, the U.S. Food and Drug Administration (FDA) approved the use of VYVGART Hytrulo for people living with generalized myasthenia gravis (gMG), a chronic autoimmune neuromuscular disease…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More